In this report (download here) , Q1 2023 Global Biopharma Market Trends and News, we cover the key Biotech/Pharma trends and developments in seven regions (US, Europe, Japan, India, China, Latin America, and Africa) for the first quarter of 2023. We have also covered the major news and developments of the top ten companies in each of these seven regions.

The key biotech/pharma trends section covers the key regulatory changes, major drug approvals, shifts in therapeutic area focus, and industry trends. We have also included the M&A and venture funding trends for the quarter and the top deals in the sector for each region.

For the company news section, we have identified the top biotech/pharma companies based on their market capitalization for public companies (or employee count for private companies). Further, we have covered company-level details and major news or events for Q1 2023.

About the author.


20 years of experience in international business development in the pharmaceutical industry. Head of commercial operations and business development for Bristol-Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years.

No Comments. Leave a comment  

Leave a Reply

Your email address will not be published. Required fields are marked *